Monashee Scales Back Structure: GPCR Bet Reassessed
A major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
Wondering about your retirement target at 40? Discover how to plan ahead for a secure financial future with our expert insights.
24,965 articlesA major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
A bold investment thesis hinges on the AI inference niche. After June 3, the market could reward execution as much as...
Berkshire Hathaway’s massive cash pile has long frustrated investors. Now the company is finally putting some of that...
The trillion-dollar club is crowded and growing. If micron makes trillion club, it could reshape memory stock bets an...
Imagine a blockbuster SpaceX IPO that raises $75 billion and pays banks a record underwriting fee. This article break...
Investors are buzzing as rare earth stock rocketing headlines surface. This article breaks down the drivers behind US...
When a CEO exits at a major fintech-adjacent firm, investors scramble for context. This article digs into what the de...
Viking Therapeutics trades around the low $30s as pivotal data for VK2735 approaches. This article breaks down whethe...
As the renewables wave grows, Clearway Energy (CWEN) stands out with a diversified solar and wind portfolio. This gui...
Micron’s stock has surged dramatically in the last year. While some analysts see meaningful upside from current level...
Sunrun’s stock tumbled on a day of mixed signals: strong quarterly revenue but cautious guidance for 2026. This artic...
As lithium demand climbs, Albemarle sits at a crossroads. This article breaks down the lithium rise again. does dynam...